Steven Cohen's RGEN Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 1.01 M shares of Repligen Corporation (RGEN) worth $164.89 M, representing 0.18% of the portfolio. First purchased in 2018-Q3, this long-term strategic position has been held for 30 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in RGEN, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 796,745 shares. Largest reduction occurred in Q3 2025, reducing 472,469 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Repligen Corporation (RGEN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Repligen Corporation (RGEN) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -434,411 | Reduce 30.15% | 1.01 M | $163.86 |
| Q3 2025 | -472,469 | Reduce 24.70% | 1.44 M | $133.67 |
| Q2 2025 | +796,745 | Add 71.36% | 1.91 M | $124.38 |
| Q1 2025 | +197,822 | Add 21.53% | 1.12 M | $127.24 |
| Q4 2024 | +594,189 | Add 183.15% | 918,623 | $143.94 |
| Q3 2024 | +9,387 | Add 2.98% | 324,434 | $148.82 |
| Q2 2024 | -226,380 | Reduce 41.81% | 315,047 | $126.06 |
| Q1 2024 | -55,468 | Reduce 9.29% | 541,427 | $183.92 |
| Q4 2023 | +596,895 | New Buy | 596,895 | $179.80 |
| Q3 2023 | -41 | Sold Out | 0 | $0.00 |
| Q2 2023 | +41 | New Buy | 41 | $141.46 |
| Q1 2023 | -84,178 | Sold Out | 0 | $0.00 |
| Q4 2022 | -222,926 | Reduce 72.59% | 84,178 | $169.31 |
| Q3 2022 | -195,237 | Reduce 38.87% | 307,104 | $187.11 |
| Q2 2022 | +346,459 | Add 222.26% | 502,341 | $162.40 |
| Q1 2022 | +43,191 | Add 38.33% | 155,882 | $188.09 |
| Q4 2021 | +36,278 | Add 47.48% | 112,691 | $264.84 |
| Q3 2021 | -321,994 | Reduce 80.82% | 76,413 | $289.00 |
| Q2 2021 | +56,840 | Add 16.64% | 398,407 | $199.62 |
| Q1 2021 | -39,838 | Reduce 10.45% | 341,567 | $194.41 |
| Q4 2020 | -285,814 | Reduce 42.84% | 381,405 | $191.63 |
| Q3 2020 | +239,625 | Add 56.04% | 667,219 | $147.54 |
| Q2 2020 | +416,867 | Add 3886.15% | 427,594 | $123.61 |
| Q1 2020 | -80,478 | Reduce 88.24% | 10,727 | $96.58 |
| Q4 2019 | -450,469 | Reduce 83.16% | 91,205 | $92.49 |
| Q3 2019 | +302,733 | Add 126.70% | 541,674 | $76.69 |
| Q2 2019 | +121,028 | Add 102.64% | 238,941 | $85.95 |
| Q1 2019 | +3,723 | Add 3.26% | 117,913 | $59.08 |
| Q4 2018 | -204,710 | Reduce 64.19% | 114,190 | $52.74 |
| Q3 2018 | +318,900 | New Buy | 318,900 | $55.46 |
Steven Cohen's Repligen Corporation Investment FAQs
Steven Cohen first purchased Repligen Corporation (RGEN) in Q3 2018, acquiring 318,900 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Repligen Corporation (RGEN) for 30 quarters since Q3 2018.
Steven Cohen's largest addition to Repligen Corporation (RGEN) was in Q2 2025, adding 1,913,190 shares worth $237.96 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 1,006,310 shares of Repligen Corporation (RGEN), valued at approximately $164.89 M.
As of the Q4 2025 filing, Repligen Corporation (RGEN) represents approximately 0.18% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Repligen Corporation (RGEN) was 1,913,190 shares, as reported at the end of Q2 2025.